- Home
- SVRA vs STK Comparison
SVRA vs STK Comparison
Compare SVRA & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- STK
- Stock Information
- Founded
- SVRA 2007
- STK 2009
- Country
- SVRA United States
- STK United States
- Employees
- SVRA N/A
- STK N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- STK Investment Managers
- Sector
- SVRA Health Care
- STK Finance
- Exchange
- SVRA Nasdaq
- STK Nasdaq
- Market Cap
- SVRA 527.2M
- STK 614.2M
- IPO Year
- SVRA N/A
- STK N/A
- Fundamental
- Price
- SVRA $3.41
- STK $36.20
- Analyst Decision
- SVRA Buy
- STK
- Analyst Count
- SVRA 8
- STK 0
- Target Price
- SVRA $6.63
- STK N/A
- AVG Volume (30 Days)
- SVRA 1.1M
- STK 38.2K
- Earning Date
- SVRA 11-11-2025
- STK 01-01-0001
- Dividend Yield
- SVRA N/A
- STK 6.60%
- EPS Growth
- SVRA N/A
- STK N/A
- EPS
- SVRA N/A
- STK N/A
- Revenue
- SVRA N/A
- STK N/A
- Revenue This Year
- SVRA N/A
- STK N/A
- Revenue Next Year
- SVRA N/A
- STK N/A
- P/E Ratio
- SVRA N/A
- STK N/A
- Revenue Growth
- SVRA N/A
- STK N/A
- 52 Week Low
- SVRA $1.89
- STK $24.95
- 52 Week High
- SVRA $4.30
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- SVRA 52.33
- STK 71.34
- Support Level
- SVRA $3.42
- STK $34.52
- Resistance Level
- SVRA $3.65
- STK $36.43
- Average True Range (ATR)
- SVRA 0.12
- STK 0.61
- MACD
- SVRA -0.04
- STK 0.03
- Stochastic Oscillator
- SVRA 12.90
- STK 72.41
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.